Published on 13 Dec 2021 on Insider Monkey via Yahoo Finance
Hedge Funds Are Coming Back To Global Blood Therapeutics Inc (GBT)
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as to maintain the desired risk profile. As a result, the relevancy of these public filings and their content is indisputable, as they may reveal numerous high-potential stocks. The following article will discuss the smart money sentiment towards Global Blood Therapeutics Inc (NASDAQ:GBT).
Global Blood Therapeutics Inc (NASDAQ:GBT) shareholders have witnessed an increase in support from the world's most elite money managers in recent months. Global Blood Therapeutics Inc (NASDAQ:GBT) was in 23 hedge funds' portfolios at the end of the third quarter of 2021. The all time high for this statistic is 31. Our calculations also showed that GBT isn't among the 30 most popular stocks among hedge funds (click for Q3 rankings).
